Your browser doesn't support javascript.
loading
Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?
Elrakaybi, Asmaa; Laubner, Katharina; Zhou, Qian; Hug, Martin J; Seufert, Jochen.
Afiliação
  • Elrakaybi A; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany; Department of Clinical Pharmacy, Ain Shams University, 11566 Cairo, Egypt.
  • Laubner K; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Zhou Q; Department of Cardiology and Angiology I, Heart Centre, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany; Department of Cardiology, University Hospital Basel, 4031 Basel, Switzerland.
  • Hug MJ; Pharmacy, Medical Centre - University of Freiburg, 79106 Freiburg, Germany.
  • Seufert J; Division of Endocrinology and Diabetology, Department of Medicine II, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany. Electronic address: jochen.seufert@uniklinik-freiburg.de.
Mol Metab ; 64: 101549, 2022 10.
Article em En | MEDLINE | ID: mdl-35863639

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito